Document Detail

Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study.
MedLine Citation:
PMID:  18023439     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To examine whether the addition of one dose of preovulatory GnRH agonist could improve implantation and pregnancy rates in GnRH antagonist IVF cycles. DESIGN: Prospective, randomized clinical trial. SETTING: University-affiliated IVF and infertility unit. PATIENT(S): Two hundred twenty-one patients intended for GnRH antagonist protocol IVF. INTERVENTION(S): Patients were prospectively randomized to two groups. The control group received hCG (5,000 U) 34 hours before oocyte aspiration, and the study group received triptorelin (0.2 mg SC) in addition to hCG. All other treatment parameters were identical. MAIN OUTCOME MEASURE(S): Oocyte pick-up day serum levels of E(2), P, LH, and FSH and implantation and pregnancy rates per started cycle and per completed cycle. RESULT(S): A total of 200 ET cycles were carried out: 97 in the study group and 103 in the control group. None of the cycle parameters of the study or control groups differed, excepting mean oocyte pick-up day FSH (11.26 IU/L [95% confidence interval (CI) 9.88-12.52] vs. 6.27 IU/L [95% CI 5.76-8.77]) and LH levels (5.19 IU/L [95% CI 4.47-5.9] vs. 3.28 IU/L [95% CI 2.22-4.18]). The implantation rate was 19.9% (52 of 261) for the study group and 13.9% (35 of 251) for the control group. The pregnancy rate in completed cycles and the ongoing pregnancy rate per ET were significantly higher in the study group than in the control group: 29.1% (30 of 103) in the control group and 44.3% (43 of 97) in the study group, and 22.3% (23 of 103) and 36.1% (35 of 97), respectively. However, the improvement in pregnancy rate per started cycle did not reach statistical significance (40.9% vs. 28.3%). CONCLUSIONS: The administration of triptorelin (0.2 mg) at the time of hCG administration in GnRH antagonist IVF cycles significantly improved overall and ongoing pregnancy rates in completed cycles but not in all started cycles. It is possible that this was achieved owing to an endometrial GnRH receptor effect, which should also be examined by direct endometrial studies.
Morey Schachter; Shevach Friedler; Raphael Ron-El; Ariel L Zimmerman; Deborah Strassburger; Orna Bern; Arieh Raziel
Related Documents :
12069389 - Interleukin 2 receptor gamma chain (gamma(c)) knockout mice show less regularity in est...
14664409 - Effect of short follicular phase with follicular maturity on conception outcome.
1601149 - The outcome of in vitro fertilization and embryo transfer in women with polycystic ovar...
16048799 - Antral follicle assessment after down-regulation may be a useful tool for predicting pr...
1095309 - Clinical trial of a low dose combined oral contraceptive ('ovranette').
19902469 - Ultrasound monitoring in patients undergoing in-vitro fertilization after methotrexate ...
17029289 - Trends of selected malformations in relation to folic acid recommendations and fortific...
8691249 - Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregna...
9105129 - General practitioners knowledge of and attitudes to the use of seat belts in pregnancy.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial     Date:  2007-11-26
Journal Detail:
Title:  Fertility and sterility     Volume:  90     ISSN:  1556-5653     ISO Abbreviation:  Fertil. Steril.     Publication Date:  2008 Oct 
Date Detail:
Created Date:  2008-10-20     Completed Date:  2008-11-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372772     Medline TA:  Fertil Steril     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1087-93     Citation Subset:  IM    
IVF and Infertility Unit, Assaf Harofeh Medical Center, Tel Aviv University, Zerifin, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Drug Therapy, Combination
Fertility Agents, Female / administration & dosage*
Fertilization in Vitro / methods,  statistics & numerical data*
Gonadotropin-Releasing Hormone / agonists*,  antagonists & inhibitors*
Infertility, Female / epidemiology*,  therapy*
Oocyte Retrieval / statistics & numerical data*
Pregnancy Rate*
Premedication / methods,  statistics & numerical data
Prospective Studies
Treatment Outcome
Reg. No./Substance:
0/Fertility Agents, Female; 33515-09-2/Gonadotropin-Releasing Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Computer-assisted motility analysis of spermatozoa obtained after spermatogonial stem cell transplan...
Next Document:  Testicular sperm extraction in a single cancerous testicle in patients with azoospermia: a case repo...